||Recombinant human VTCN1 extracellular domain cDNA (25-259aa, Isoform-1, derived from BC074729) fused with T7/His/TEV cleavage site Tag at N-terminal was expressed in E. coli.
||1.0 mg/ml, sterile-filtered, in 20 mM pH 8.0 Tris-HCl Buffer, with proprietary formulation of NaCl, KCl, EDTA, Sucrose and DTT.
||MASMTGGQQMGRGHHHHHHGNLYFQGEFLIIGFGISGRHSITVTTVASAGNIGEDGILSCTFEPDIKLSDIVIQW LKEGVLGLVHEFKEGKDELSEQDEMFRGRTAVFADQVIVGNASLRLKNVQLTDAGTYKCYIITSKGKGNANLEYK TGAFSMPEVNVDYNASSETLRCEAPRWFPQPTVVWASQVDQGANFSEVSNTSFELNSENVTMKVVSVLYNVTINN TYSCMIENDIAKATGDIKVTESEIKRRSHLQLLNSKAS
||>90% by SDS-PAGE
||1. May be used for in vitro VTCN1 mediated T cell differentiation regulation study with this protein as either soluble factor or coating matrix protein.2. May be used for mapping VTCN1 protein-protein interaction assay.3. Potential biomarker protein for clinical applications such as monitoring pancreatic cancer progression.4. As antigen for specific antibody production.
||Keep at -80 centigrade for long term storage. Product is stable at 4 centigrade for at least 30 days.